Instil Bio, Inc. (TIL)Healthcare | Biotechnology | Dallas, United States | NasdaqCM
7.58 USD
-0.28
(-3.562%) ⇩
(Aug. 28, 2026, 4 p.m.
EDT)
After hours: 7.58 -0.25 (-0.250%) ⇩ (Aug. 28, 2026, 4:10 p.m. EDT) |
Hot Take ↕ | Aug. 22, 2026, 2:28 a.m. EDT
The immediate outlook is severely clouded by a catastrophic collapse in the business model. The company recently discontinued clinical development for a key asset (AXN-2510) and terminated a major collaboration agreement, signaling a fundamental failure in its pipeline execution. This operational disaster is reflected in the price action, which has erased over 92% of its value since 2021, despite a brief, likely speculative rebound in 2025. With negative earnings, a forward P/E that implies massive future losses, and a lack of analyst coverage, there is no credible path to recovery. The short-term momentum remains fragile as the stock tests support levels, and the long-term investment case is effectively zero given the destroyed competitive moat and capital destruction. Furthermore, there is no dividend income to offset these risks. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.024761 |
| MSTL | 0.025631 |
| AutoARIMA | 0.025660 |
| AutoETS | 0.025718 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 56% |
| H-stat | 1.71 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.484 |
| Excess Kurtosis | -0.73 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 81.412 |
| Market Cap | 51,407,384 |
| Forward P/E | -0.52 |
| Beta | 1.91 |
| Website | https://instilbio.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.73100615 |
| Address1 | 3,963 Maple Avenue |
| Address2 | Suite 350 |
| All Time High | 589.8 |
| All Time Low | 5.67 |
| Ask | 9.72 |
| Ask Size | 2 |
| Audit Risk | 6 |
| Average Daily Volume10 Day | 7,410 |
| Average Daily Volume3 Month | 12,524 |
| Average Volume | 12,524 |
| Average Volume10Days | 7,410 |
| Beta | 1.911 |
| Bid | 5.48 |
| Bid Size | 2 |
| Board Risk | 8 |
| Book Value | 15.833 |
| City | Dallas |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 9 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 7.58 |
| Current Ratio | 21.666 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,786,665,600 |
| Day High | 7.83 |
| Day Low | 7.4503 |
| Debt To Equity | 81.412 |
| Display Name | Instil Bio |
| Earnings Timestamp End | 1,772,631,000 |
| Earnings Timestamp Start | 1,772,631,000 |
| Ebitda | -36,661,000 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -1.886 |
| Enterprise Value | 69,149,376 |
| Eps Forward | -14.64 |
| Eps Trailing Twelve Months | -4.4 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 7.4717 |
| Fifty Day Average Change | 0.10829973 |
| Fifty Day Average Change Percent | 0.0144946575 |
| Fifty Two Week Change Percent | -73.10062 |
| Fifty Two Week High | 33.833 |
| Fifty Two Week High Change | -26.253 |
| Fifty Two Week High Change Percent | -0.77595836 |
| Fifty Two Week Low | 5.67 |
| Fifty Two Week Low Change | 1.9099998 |
| Fifty Two Week Low Change Percent | 0.33686063 |
| Fifty Two Week Range | 5.67 - 33.833 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,616,160,600,000 |
| Float Shares | 3,621,440 |
| Forward Eps | -14.64 |
| Forward P E | -0.51775956 |
| Free Cashflow | 81,813,504 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 17 |
| Fullday Change | -0.28 |
| Fullday Change Percent | -3.56234 |
| Fullday Price | 7.58 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,785,542,400 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.06561 |
| Held Percent Institutions | 0.62497 |
| Implied Shares Outstanding | 6,781,977 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,701,993,600 |
| Last Split Factor | 1:20 |
| Long Business Summary | Instil Bio, Inc., a biopharmaceutical company, focuses on identifying and advancing therapeutic opportunities. It seeks to in-license or acquire and develop additional novel therapeutic candidates in diseases with significant unmet medical need. Instil Bio, Inc. was incorporated in 2018 and is headquartered in Dallas, Texas. |
| Long Name | Instil Bio, Inc. |
| Market | us_market |
| Market Cap | 51,407,384 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_638929728 |
| Most Recent Quarter | 1,782,777,600 |
| Net Income To Common | -30,281,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 52,526,404 |
| Number Of Analyst Opinions | 1 |
| Open | 7.79 |
| Operating Cashflow | -23,612,000 |
| Operating Margins | 0.0 |
| Overall Risk | 9 |
| Payout Ratio | 0.0 |
| Phone | 972 499 3350 |
| Post Market Change | -0.25 |
| Post Market Change Percent | -3.192848 |
| Post Market Price | 7.58 |
| Post Market Time | 1,787,947,805 |
| Previous Close | 7.86 |
| Price Hint | 2 |
| Price To Book | 0.47874692 |
| Profit Margins | 0.0 |
| Quick Ratio | 21.09 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.2800002 |
| Regular Market Change Percent | -3.5623436 |
| Regular Market Day High | 7.83 |
| Regular Market Day Low | 7.4503 |
| Regular Market Day Range | 7.4503 - 7.83 |
| Regular Market Open | 7.79 |
| Regular Market Previous Close | 7.86 |
| Regular Market Price | 7.58 |
| Regular Market Time | 1,787,947,200 |
| Regular Market Volume | 14,278 |
| Return On Assets | -0.10772 |
| Return On Equity | -0.25334 |
| Sand P52 Week Change | 0.20504117 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 8 |
| Shares Outstanding | 6,781,976 |
| Shares Percent Shares Out | 0.025999999 |
| Shares Short | 176,320 |
| Shares Short Previous Month Date | 1,784,073,600 |
| Shares Short Prior Month | 203,828 |
| Short Name | Instil Bio, Inc. |
| Short Percent Of Float | 0.0438 |
| Short Ratio | 17.93 |
| Source Interval | 15 |
| State | TX |
| Symbol | TIL |
| Target High Price | 7.0 |
| Target Low Price | 7.0 |
| Target Mean Price | 7.0 |
| Target Median Price | 7.0 |
| Total Cash | 69,678,000 |
| Total Cash Per Share | 10.274 |
| Total Debt | 87,420,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -4.4 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 8.65285 |
| Two Hundred Day Average Change | -1.0728502 |
| Two Hundred Day Average Change Percent | -0.12398808 |
| Type Disp | Equity |
| Volume | 14,278 |
| Website | https://instilbio.com |
| Zip | 75,219 |